Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Sanj K. Patel currently holds 76,174 shares of Kiniksa Pharmaceuticals, Ltd. (KNSA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sanj K. Patel has been a net seller of KNSA stock. They have purchased $0 and sold $64.1M worth of shares.
Sanj K. Patel's most recent insider trade was on Apr 7, 2026, when they sold 9,991 shares at $0.00 per share.
Sanj K. Patel serves as Executive at Kiniksa Pharmaceuticals, Ltd. (KNSA). They have executed 177 insider transactions totaling $64.1M over their tenure at the company.
Sanj K. Patel holds the position of Executive at Kiniksa Pharmaceuticals, Ltd., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 14 years and currently hold a stake valued at $0.
Sanj K. Patel has shown a selling trading pattern, with $0 in total purchases and $64.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Sanj K. Patel was on Oct 20, 2025, when they sold $3.8M worth of KNSA shares. This transaction involved 98,934 shares at $38.81 per share.
Sanj K. Patel currently owns 76,174 shares of Kiniksa Pharmaceuticals, Ltd. (KNSA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Sanj K. Patel's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Sanj K. Patel has 177 Form 4 filings on record as an insider at Kiniksa Pharmaceuticals, Ltd..
Set alerts for Sanj K. Patel and 40,000+ other insiders.